• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PER

PERCHERON THERAPEUTICS LIMITED

13.6% ! 1.0¢
Market Cap $10.33M  !
Healthcare Biotechnology
Add to My Watchlist

Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a... Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a biotechnology company. The Company is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The Company is conducting a Phase II clinical trial of ATL1102 in DMD patients.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PER
Ann: New Preclinical Data Reported for HMBD-002 in Breast Cancer 		12:51 26 6.4K
12:51 Last post  lockitt Comments Created with Sketch.  26  Views Created with Sketch.  6.4K 
PER
Ann: Percheron licenses HMBD-002 from Hummingbird Bioscience
2
12:00 71 22K
12:00 Last post  Bluesky24 Comments Created with Sketch.  71  Views Created with Sketch.  22K 
PER
Ann: Quarterly Activities Report and Appendix 4C 		06/08/25 11 3.4K
06/08/25 Last post  P3COrion Comments Created with Sketch.  11  Views Created with Sketch.  3.4K 
PER
Ann: New Preclinical Data Reported for HMBD-002 		28/07/25 6 2.9K
28/07/25 Last post  Insulsa Comments Created with Sketch.  6  Views Created with Sketch.  2.9K 
PER
Ann: Topline Six-Month Results From Phase IIb Study of Avicursen
2 3 4
22/07/25 200 95K
22/07/25 Last post  Cuprum29 Comments Created with Sketch.  200  Views Created with Sketch.  95K 
PER
Ann: Change of Director's Interest Notice - Dr James Garner 		03/07/25 11 5.1K
03/07/25 Last post  dazatoN Comments Created with Sketch.  11  Views Created with Sketch.  5.1K 
PER
Ann: Ceasing to be a substantial holder from PVL 		30/06/25 6 2.1K
30/06/25 Last post  Motors Comments Created with Sketch.  6  Views Created with Sketch.  2.1K 
PER
Ann: Percheron Therapeutics Limited Corporate Presentation 		27/06/25 10 2.7K
27/06/25 Last post  joe76 Comments Created with Sketch.  10  Views Created with Sketch.  2.7K 

See All Discussions arrow Created with Sketch.

Timeline

New Preclinical Data Reported for HMBD-002 in Breast Cancer
06 Aug 08:17
 
Quarterly Activities Report and Appendix 4C
31 Jul 08:20
 
New Preclinical Data Reported for HMBD-002
23 Jul 08:46
 
Change of Director's Interest Notice - Dr James Garner
01 Jul 08:39
 
Ceasing to be a substantial holder from PVL
30 Jun 11:05
 
Percheron Therapeutics Limited Corporate Presentation
27 Jun 08:25
 
View More arrow Created with Sketch.

Featured News

AII Building assets, producing critical minerals and slashing dependency on China
right-arrow Created with Sketch.
NEWS Expert Exchange: Laretive's 4 key strategies to picking ASX winners
right-arrow Created with Sketch.
NEWS Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed
right-arrow Created with Sketch.
NEWS RBA's inflation trick: Is the number lying to us?
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 32
right-arrow Created with Sketch.
NEWS What the hell is wrong with ASX Ltd? The hits keep coming, and now CBOE looms
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.0¢ 		Change
-0.002(13.6%) 		Mkt cap ! $10.33M
Open High Low Value Volume
1.1¢ 1.1¢ 1.0¢ $33.35K 3.267M

Buyers (Bids)

No. Vol. Price($)
6 11081783 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 6192866 5
View Market Depth
Last trade - 12.49pm 11/08/2025 (20 minute delay) ?
Last
0.9¢ 		  Change
-0.002 ( 18.2 %)
Open High Low Volume
1.1¢ 1.1¢ 0.9¢ 5500861
Last updated 12.11pm 11/08/2025 ?
PER (ASX) Chart

Top Stories

Can the market squeeze IDP Education's shorters? As of Week 33, it looks possible

IDP Education (ASX:IEL), a company that ultimately trains up foreign students moving to Australia, has long been one of the most...
Monday's HotCopper trends: DRO civ counterdrone, Dateline drill hits | Aug 11 DroneShield (ASX:DRO) has captured the most attention across the HotCopper forums through Week 33’s first trade day, sparking excitement with its new @SentryCiv,” a subscription-based AI counterdrone solution.Listen to the HotCopper podcast for in-depth discu...
DroneShield's civilian counter-drone tech lands with a buzz Imagine a superhero, not in a cape, but in the form of sleek software quietly watching the skies. Enter SentryCiv, DroneShield’s (ASX:DRO) newest brainchild.The company says its an embryonic leap in airspace protection, designed not for warzones, but for the everyday workers taske...
Trump's not talking about Greenland – so why is ETM up +130%? Sixty Minutes is, in many ways, peak boomer. The not-so-shiny-anymore crown jewel of a media brand now more invested in property...
The cash flow on demand strategy that works This week on Money and Investing, Mitch Olarenshaw and I break down the strategy behind Cash Flow on Demand @ a proven system for generating consistent income from the sharemarket with lower risk.1. The cash flow on demand strategyThis income strategy has been our flagship approach at Australian ...

Featured News

NEWS The 10 hot stocks HotCopper users watchlisted in Week 32
right-arrow Created with Sketch.
NEWS What the hell is wrong with ASX Ltd? The hits keep coming, and now CBOE looms
right-arrow Created with Sketch.
NEWS Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed
right-arrow Created with Sketch.
NEWS RBA's inflation trick: Is the number lying to us?
right-arrow Created with Sketch.
AII Building assets, producing critical minerals and slashing dependency on China
right-arrow Created with Sketch.
NEWS Expert Exchange: Laretive's 4 key strategies to picking ASX winners
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.